Document is current
Any future updates will be listed below
-
Authors
Li, Jia-Kai
Zhao, Yi-Chang
Wu, Shi-Qi
Zhang, Yu-Kun
Liu, Jia-Yi
Fu, Rao
Zhang, Bi-Kui
Yan, Miao
-
Funding
Funding for this research was provided by:
the Teaching Reform Program for Graduate Education at Central South University (2023JGB039, 2023JGB039, 2023JGB039, 2023JGB039, 2023JGB039, 2023JGB039, 2023JGB039, 2023JGB039)
Chinese Pharmaceutical Association Hospital Phamacy department (CPA-Z05-ZC-2024002, CPA-Z05-ZC-2024002, CPA-Z05-ZC-2024002, CPA-Z05-ZC-2024002, CPA-Z05-ZC-2024002, CPA-Z05-ZC-2024002, CPA-Z05-ZC-2024002, CPA-Z05-ZC-2024002)
Hunan Provincial Health High-Level Talent Scientific Research Project (R2023061, R2023061)
Hunan Provincial Education Department under the Hunan Provincial Degree and Graduate Education Reform Project (2023JGYB041, 2023JGYB041, 2023JGYB041, 2023JGYB041, 2023JGYB041, 2023JGYB041, 2023JGYB041)
- License Information
-
More Information
Article History
Received: 27 May 2025
Accepted: 14 August 2025
First Online: 2 September 2025
Declarations
:
: All participants in this study provided electronic informed consent prior to their involvement. The study protocol was approved by the Ethics Committee of the Second Xiangya Hospital, Central South University (Approval No.: LYEC2024-0220). This study did not involve any human or animal experimentation procedures.This study was approved by the Clinical Research Ethics Committee of the Second Xiangya Hospital, Central South University (Approval No.: LYEC2024-0220).
: The authors declare no competing interests.
